Anthony Don (don@cs.umd)
40 likes | 166 Vues
This study analyzes data from the National Ambulatory Medical Care Survey, focusing on drug mentions during physician visits by patients aged 25 and older. It reveals a significant rise in drug mentions per 100 population from 1995 to 2004, with a notable acceleration in 2003-2004. Specific drug classes, including cardiovascular-renal, pain-relief, and central-nervous system agents, contributed to this increase. Potential hypotheses for these trends include the aging population, increasing prevalence of severe diseases, and heightened awareness of health and nutrition.
Anthony Don (don@cs.umd)
E N D
Presentation Transcript
Anthony Don(don@cs.umd.edu) Data from the National Ambulatory Medical Care Survey on drug mentions at physician office visits by patients aged 25 years and over. Author: NCHS. http://www.cdc.gov/nchs/health_data_for_all_ages.htm
Drug mentions Rates of drug mentions per 100 population Overall increase of the number of drug mentions per 100 population over the 1995-2004 period. The increase accelerates in 2003-2004. The contribution of specific drug classes to the overall increase is visible, especially : cardiovascular-renal drugs, pain-relief drugs,central-nervous system and metabolic/nutrient agents.
Aging population ? This suggests several hypothesis to explain these trends : - increase of severe diseases due to an aging population, - harder stress conditions - more concern about nutrition and health. Distribution of age classes across the population
Distribution of mentions Distribution of drug mentions across age classes People from the older age classes use a larger part of the overall mentions.